Chapter 9: Anxiety Disorders

The material distinguishes between ten major anxiety syndromes, including generalized anxiety disorder, panic disorder, social anxiety disorder, specific phobias, obsessive-compulsive disorder, and post-traumatic stress disorder, emphasizing the clinical importance of differential diagnosis for appropriate intervention selection. The chapter elucidates the neurobiological substrate of anxiety by exploring the amygdala's role in threat detection, the hypothalamic-pituitary-adrenal axis's regulation of stress hormones, and the neurotransmitter systems implicated in anxious states, particularly the serotonergic and gamma-aminobutyric acid systems. The fight-or-flight response is examined as a fundamental physiological mechanism that becomes dysregulated in anxiety disorders, with stress hormones such as cortisol and adrenaline producing characteristic somatic and cognitive symptoms. The chapter addresses how early developmental trauma and adverse experiences reshape neural circuitry governing stress regulation and emotional processing, creating vulnerability to persistent anxiety pathology. Pharmacological interventions are systematically reviewed, including selective serotonin reuptake inhibitors as first-line agents, benzodiazepines for acute symptom management, beta-blockers for performance anxiety, and other psychotropic classes with supporting evidence. Psychological and behavioral treatment strategies are integrated throughout, highlighting cognitive-behavioral therapy, exposure-based interventions, systematic desensitization, and relaxation techniques as core components of comprehensive anxiety management. The chapter synthesizes biological and psychological perspectives to demonstrate how multimodal treatment approaches addressing both neurochemical and cognitive-behavioral factors produce optimal clinical outcomes for individuals experiencing anxiety disorders.